Skip to content
JLM-BioCity
  • HOME
  • ABOUT US
    • What is JLM-BioCity?
    • What We Do
    • Board of Advisors
    • Meet the Team
  • EVENTS
    • Past Events
    • Event Clips
  • RESOURCES
    • JLM Bio Innovation
    • JLM Companies
    • JLM Landscape
    • BioTips
    • Blog
    • Briefs
  • JOIN US
    • Our Partners
    • Become a Partner
  • CONTACT US
Menu Close
  • HOME
  • ABOUT US
    • What is JLM-BioCity?
    • What We Do
    • Board of Advisors
    • Meet the Team
  • EVENTS
    • Past Events
    • Event Clips
  • RESOURCES
    • JLM Bio Innovation
    • JLM Companies
    • JLM Landscape
    • BioTips
    • Blog
    • Briefs
  • JOIN US
    • Our Partners
    • Become a Partner
  • CONTACT US

JLM-BioCity Innovations

  1. Home>
  2. Resources>
  3. JLM-BioCity Innovations>
  4. Page 37
JLM-Biomed Pharma

JLM based Entera Bio sets terms for $60m Nasdaq IPO

January 21, 2018

DNA Biomedical Solutions Ltd. (TASE: DNA) subsidiary Entera Bio has set the terms for a Nasdaq IPO to raise $50 million – $60 million at a company valuation

Read More »
JLM-BioCity Pharma Diabetes

Oramed Pharma’s CEO Issues Letter to Shareholders

January 21, 2018

Jan 19, 2017 Dear Shareholders, All the hard work and dedication in 2017 has successfully positioned Oramed to initiate a U.S. based multicenter 90-day treatment

Read More »
JLM-BioCIty Biomed visually impaired AI

OrCam Launched Next Generation of Artificial Vision for the Visually Impaired

January 21, 2018

Janaury 7, 2017  OrCam displayed their artificial vision technology, OrCam MyEye 2.0, at CES 2018. MyEye was been named a CES Innovation Awards honoree and a finalist in the last gadget standing

Read More »

JLM based Salignostics Ltd is carrying out free saliva based pregnancy tests for a limited period of time

January 21, 2018

Dec 14, 2017 JLM based Salignostics Ltd has developed a novel pregnancy rapid home- test utilizing saliva. This is the first saliva pregnancy OTC product

Read More »

Kitov Pharmaceuticals Announces Receipt of FDA’s Favorable Response to NT219’s pre-IND Meeting Package

January 7, 2018

Nov 11, 2017 – NT219 works by overcoming drug resistance of pancreatic cancer to various oncology drugs.  Kitov Pharmaceuticals (NASDAQ: KTOV; TASE: KTOV), an innovative biopharmaceutical

Read More »

Granalix BioTechnologies, founded by Prof Ruth Gabizon, is marketing a Novel Food Additive Based On Pomegranate Oil For Protection From Neurodegenerative Diseases

December 27, 2017

Granalix BioTechnologies, following its commercial launch last year of GranaGard™ a food supplement based on pomegranate oil that was shown to prevent neurodegeneration diseases in mouse models,

Read More »
JLM-BioCity Shaarei Zedek Pharma

Updated Version of Oncological Drugs Rating Tool, developed by Prof. Nathan Cherny from Shaare Zedek Medical Center

December 27, 2017

Novermber 10, 2017 The new version of an international oncological drugs rating tool, developed by Prof. Nathan Cherny from Shaare Zedek, will – for the

Read More »

JLM based Neteera Expands Market Reach and Senior Management

December 14, 2017

Dec 12, 2017: Neteera Technologies Ltd. [http://www.neteera.com ] announced the addition of Jason Rudd and Ilya Vatsel to the company’s senior management team bringing a wealth

Read More »
JLM-BioCity Biotech

Investors Initiate Tender Offer to Take BioCanCell Private Ahead of Planned Fundraising Round

December 14, 2017

JERUSALEM, Dec. 11, 2017 (GLOBE NEWSWIRE) — BioCancell Therapeutics (TASE:BICL), http://www.biocancell.com/ a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapies to treat cancer,

Read More »
« Previous Page1 Page2 Page3 Page4 Page5 Page6 Page7 Page8 Page9 Page10 Page11 Page12 Page13 Page14 Page15 Page16 Page17 Page18 Page19 Page20 Page21 Page22 Page23 Page24 Page25 Page26 Page27 Page28 Page29 Page30 Page31 Page32 Page33 Page34 Page35 Page36 Page37 Page38 Page39 Page40 Page41 Page42 Next »

JLM-BioCity Upcoming Events

More JLM-BioCity events coming soon…

What People Say About JLM-BioCity

Alexander Naslednikov

JLM-BioCity Member Alexander Naslednikov

Excellent organization (from the timing to food), the quality of the audience was superior, we personally got a lot of hot leads.

-Alexander Naslednikov, Founder and CEO, Med.me

Tal Or

JLM-BioCity Member Tal Or

One of the best meetups organizations and a very important source of information and connections for startups.

-Tal Or, Co-Founder, ATLASense Biomed Ltd.

Hemda Idel

JLM BioCity Member Hemda Idel

Very informative and eye-opening event. Thank you for the great hospitality.

– Hemda Idel, founder, SLEEP ASAP

Aviv Marom

JLM BioCity Member Aviv Marom

There was an excellent networking atmosphere with impressive Panelists as well as high-quality audience participants. I strongly recommend paying attention to future events.

-Aviv Marom, Director, Strategic Partnerships, Samsung Research, Israel

Aurélie Schwarzbach

Such an interesting lecture and great people attending!

– Aurélie Schwarzbach, Clinical Project Manager, Gamida Cell Ltd.

Zeev Malyutin

Thank you all for the great evening, it was a pleasure to see such a good and diverse set of Biomed minded people in Jerusalem!

– Zeev Malyutin, Protein Department Head, Merck KGaA

Gideon Silberman

JLM BioCity Member Gideon Silberman

Excellent event. Good speakers, interesting audience. Well done!

– Gideon Silberman, Director of Business Development, Partner and Co-Founder, Aneeva.com

Immanuel Lerner

Immanuel Lerner CEO, Pepticom

I believe in the idea of JLM-BioCity. It is good that there is an organization that represents the life science companies in Jerusalem and provides an excellent platform for networking through its regular meetings.

– Immanuel Lerner CEO, Pepticom

Dror Chevion

Dror Chevion Concenter BioPharma

JLM-BioCity’s events are well organized with a professional approach. You can feel a “homey” atmosphere around the people of a well-maintained bio-community in Jerusalem. Team members always make sure the guests feel welcome and connected to the right people for possible collaborations. There are clearly visible good-will and dedication to lead the members of the bio-community and the city as a whole to success.

– Dror Chevion  CEO, Concenter BioPharma

Ian Solomon

Ian Solomon CTO, OmnySense Ltd

The JLM BioCity networking events on Zoom keeps getting better.  For OmnySense they have provided an excellent forum in which to present our company, and the break-out sessions facilitate direct discussion with a broad range of potential partners and investors.

-Ian Solomon CTO, OmnySense Ltd.

Moshe Lebowitz

Moshe Lebowitz with Jerusalem Mayor Moshe Leon - Credit Dr George Lowell

Because every biotech and medtech professional knows that Jerusalem BioCity consistently delivers world-class programming, the best professionals always show up and the networking before and after the events is worth its time in gold.

– Moshe Lebowitz, CEO, Healables Digital Health | Healables: Wearables that Heal

JLM-BioCity in THE MARKER

JLM-BioCity was recently written up in THE MARKER (in Hebrew). To see the article, click here.

Strategic Partners

Platinum

Gold

Silver

JLM-BIOCITY is a division of the Jerusalem Business Networking Forum (JBNF)

Contact us at

+972-(0)54-973-0029

info at jlm-biocity.org

Follow us

Linkedin Facebook-f Youtube

Home

About

What’s Happening

Resources

Become a Partner

Become a Member

JLM-BioSynergy

Contact Us

Copyright © 2020 JLM-BioCity | All rights reserved